Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Published Apr 1, 2021 · J. Gilés, P. Alamá, P. Gámiz
Fertility and sterility
21
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayMedroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist for oocyte donation, with similar ovarian response and reproductive outcomes.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.